Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001225208-13-025709
Filing Date
2013-12-18
Accepted
2013-12-18 17:34:27
Documents
1
Period of Report
2013-12-01

Document Format Files

Seq Description Document Type Size
1 doc4a.html 4/A  
1 doc4a.xml 4/A 3159
  Complete submission text file 0001225208-13-025709.txt   4457
Mailing Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 MCDONNELL BLVD. HAZELWOOD MO 63042
Business Address
Harbaugh Matthew K (Reporting) CIK: 0001578368 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35803 | Film No.: 131286176